98%
921
2 minutes
20
Radiomics is a discipline that involves studying medical images through their digital data. Using "artificial intelligence" algorithms, radiomics utilizes quantitative and high-throughput analysis of an image's textural richness to obtain relevant information for clinicians, from diagnosis assistance to therapeutic guidance. Exploitation of these data could allow for a more detailed characterization of each phenotype, for each patient, making radiomics a new biomarker of interest, highly promising in the era of precision medicine. Moreover, radiomics is non-invasive, cost-effective, and easily reproducible in time. In the field of oncology, it performs an analysis of the entire tumor, which is impossible with a single biopsy but is essential for understanding the tumor's heterogeneity and is known to be closely related to prognosis. However, current results are sometimes less accurate than expected and often require the addition of non-radiomics data to create a performing model. To highlight the strengths and weaknesses of this new technology, we take the example of hepatocellular carcinoma and show how radiomics could facilitate its diagnosis in difficult cases, predict certain histological features, and estimate treatment response, whether medical or surgical.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093101 | PMC |
http://dx.doi.org/10.3390/diagnostics13071303 | DOI Listing |
Crit Rev Oncol Hematol
September 2025
Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address:
Hepatocellular carcinoma (HCC) is a common and complex malignant tumor whose etiology is influenced by a variety of factors and exhibits different outcomes during disease progression. HCC is distinguished by the triggering of various cell death pathways, for example ferroptosis, cuproptosis, and PANoptosis. This review provides insights into the current understanding of the interactions between reactive oxygen species (ROS) and these novel mechanisms of cell death in HCC, highlighting their significance in disease pathogenesis and their potentiality as therapeutic goals.
View Article and Find Full Text PDFClin Chem
August 2025
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Background: Protein biomarkers are routinely measured for disease diagnosis and prognosis in clinical laboratories. Since most assays focus on protein quantity, information about proteoforms is often not acquired. Proteoforms of a protein represent the complex integration of genetic polymorphism, alternative splicing of RNA transcripts, and post-translational modifications (PTMs) on the amino-acid backbone.
View Article and Find Full Text PDFLiver Int
September 2025
Biological Resource Center/Biobank, Fondazione "Ca Granda" IRCCS Ospedale Maggiore Policlinico, Milano, Italy.
Metabolic dysfunction associated steatohepatitis (MASH), formerly known as NASH, represents one of the leading causes of chronic liver disease worldwide. Its high prevalence is driven by insulin resistance, obesity and type 2 diabetes (T2D) and is associated with cardiovascular disease. The main driver of liver damage is fat accumulation in hepatocytes leading to inflammation and fibrosis development.
View Article and Find Full Text PDFFront Cell Infect Microbiol
August 2025
Institute of Infection, Immunology and Tumor Microenvironment, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Medical College, Wuhan University of Science and Technology, Wuhan, China.
Oral dysbiosis increases the risk of oral diseases and systemic diseases, with many related conditions overlapping with systemic diseases triggered by gut dysbiosis. Studies have shown that the oral cavity serves as an endogenous reservoir for gut microbial strains, influencing the homeostasis of both oral and gut microbiota through interactions involving bacterial translocation, microbial metabolites, immune cells, and inflammatory factors. In specific disease contexts, certain microbial communities [e.
View Article and Find Full Text PDFInt J Cancer
August 2025
Heilongjiang Province Key Laboratory of Child Development and Genetic Research, Harbin Medical University, Harbin, Heilongjiang, China.
Although defects in Rho GTPases have been implicated in cancer, a systematic assessment of the alterations in Rho GTPases and their regulators that facilitate conformational cycling between the active GTP-bound and inactive GDP-bound Rho GTPases is lacking across human cancers. Here, we depicted a comprehensive molecular characterization of 169 genes encoding Rho GTPases and their regulators, utilizing multi-omics data of 9125 tumor samples across 33 cancer types from The Cancer Genome Atlas. Relevant findings were consolidated using mRNA expression profiles from 10,107 samples spanning seven distinct cancer types, along with data from multiple hepatocellular carcinoma (HCC) cohorts comprising 673 patients.
View Article and Find Full Text PDF